Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-02

Clinical Trial Update: A Study of Abatacept in Patients With Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 study of abatacept in active ulcerative colitis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2010-12-02